Literature DB >> 11219247

Oral contraceptives: current status.

R T Burkman1.   

Abstract

During the past four decades, oral contraceptives have remained a safe and effective method of birth control. Reductions in the estrogen and progestin dosages have significantly decreased the incidence of cardiovascular complications. The association between oral contraceptives and breast cancer appears to be primarily because of detection bias or possibly a promotional effect. Despite the changes in formulation, the problems related to side effects have not been totally solved. Because compliance and successful use is strongly affected by side effects, improvement in this area is probably the biggest challenge faced by developers of oral contraceptives. It is also clear that there are a growing number of significant noncontraceptive benefits that accrue in oral contraceptive users. Unfortunately, many women do not know about these benefits. Thus, one of the issues that providers need to continue to address is how to provide better information about oral contraceptives and contraception in general to patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219247     DOI: 10.1097/00003081-200103000-00010

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  7 in total

Review 1.  Clinical trials of treatments for stroke.

Authors:  John Blass
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

2.  Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing.

Authors:  Annoesjka Novák; Christine de la Loge; Linda Abetz
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2010-04-27       Impact factor: 3.375

4.  Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2008-10-28       Impact factor: 3.375

5.  Non-contraceptive benefits of oral hormonal contraceptives.

Authors:  Adolf E Schindler
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

6.  Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.

Authors:  Brian Custer; W T Longstreth; Leslie E Phillips; Thomas D Koepsell; Gerald Van Belle
Journal:  BMC Cancer       Date:  2006-06-07       Impact factor: 4.430

7.  Hormonal content and potency of oral contraceptives and breast cancer risk among young women.

Authors:  M D Althuis; D R Brogan; R J Coates; J R Daling; M D Gammon; K E Malone; J B Schoenberg; L A Brinton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.